ATI RN
ATI Capstone Pharmacology Assessment 2 Quizlet Questions
Question 1 of 5
Regarding antibiotic resistance:
Correct Answer: B
Rationale: Beta-lactamase isn't the primary resistance mechanism in pneumococci (PBP alteration is), so that's false. Penicillin's poor penetration into gram-negative bacteria due to outer membranes is a true statement, a common resistance factor. Altered penicillin-binding proteins (PBPs) drive pneumococcal resistance, not the main general mechanism, though true in context. Methicillin resistance in Staph (MRSA) is due to mecA gene producing altered PBPs, not just beta-lactamase, so that's false. Penetration issues in gram-negatives are a fundamental barrier, guiding beta-lactam design like piperacillin.
Question 2 of 5
Graded dose-response curves are most useful for determining
Correct Answer: A
Rationale: Graded dose-response curves plot individual response intensity to dose increases (e.g., pain relief), a pharmacodynamic tool. Population curves (e.g., ED50) suit groups, not individuals. Large or small groups aggregate data, missing individual nuance. Individual focus defines graded curves, key for tailoring therapy.
Question 3 of 5
The patient has been receiving amitriptyline (Elavil) for 2 weeks. He tells the nurse he doesn't think this medicine is working, as he is still depressed. What is the best response by the nurse?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
A 48-year-old woman with 2-year history of rheumatoid arthritis has not had sufficient relief with methotrexate alone. Her physician prescribes a biologic TNF-α inhibitor that consists of a recombinant human IgG fused to TNF-α receptor. Which of the following drugs is this?
Correct Answer: C
Rationale: Rheumatoid arthritis (RA) progression despite methotrexate warrants a TNF-α inhibitor. The description-recombinant human IgG fused to TNF-α receptor-points to Etanercept . Adalimumab and Golimumab are monoclonal antibodies against TNF-α, not receptor fusions. Certolizumab is a PEGylated Fab fragment, not IgG-based. Etanercept , a fusion protein, binds TNF-α, neutralizing it, and matches the question's structure. Infliximab (E) is a chimeric antibody. Etanercept's unique receptor-IgG design distinguishes it, effectively reducing RA inflammation by sequestering TNF-α, a key cytokine, making it the precise answer here.
Question 5 of 5
A 52-year-old woman with a history of recurrent urinary tract infections complains of easy bruising as well as chronic fatigue. She is maintained on daily antibiotic prophylaxis with trimethoprim. Which of the following hematologic effects is likely as a result of long-term therapy with trimethoprim?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.